GlassScriptPhysician profile
Jacques T Moua
NPI 1992931737
$1,787.84
in general payments reported to CMS, 2019-2025
27 companies · $313 in 2025
The $313 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $279 · 2021: $180 · 2022: $19.80 · 2023: $312 · 2024: $500 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $333.09 | 2020-2025 | |
| Glaxosmithkline, LLC. | $145.76 | 2019-2024 | Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $136.27 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $128.70 | 2020-2021 | |
| Abbott Laboratories | $121.30 | 2023-2025 | Freestyle Libre 3, Eterna |
| Pfizer INC. | $100.76 | 2019-2024 | |
| Gilead Sciences, INC. | $96.21 | 2019-2023 | |
| Dexcom, INC. | $90.22 | 2024 | Dexcom G6 Transmitter |
| Supernus Pharmaceuticals, INC. | $76.27 | 2019-2021 | |
| Amgen INC. | $72.17 | 2023-2025 | Evenity, Repatha |
| Lilly USA, LLC | $61.05 | 2024 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $59.75 | 2019-2024 | Farxiga, Airsupra |
| Merck Sharp & Dohme LLC | $42.53 | 2019-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Insulet Corporation | $40.75 | 2025 | Omnipod |
| Phathom Pharmaceuticals, INC. | $37.90 | 2024-2025 | Voquezna |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $29.27 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astellas Pharma US INC | $27.31 | 2019-2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $25.44 | 2019-2020 | |
| Allergan, INC. | $24.50 | 2020 | |
| Nestle Healthcare Nutrition INC. | $23.94 | 2020-2021 | |
| Axsome Therapeutics, INC. | $22.74 | 2024 | Auvelity |
| Inspire Medical Systems, INC. | $19.06 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.14 | 2023 | |
| Renalytix Ai, INC. | $16.12 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Genentech USA, INC. | $15.27 | 2020 | |
| Organon LLC | $12.81 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacques Moua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.